EGF receptor trafficking: consequences for signaling and cancer
about
The formation and function of ER-endosome membrane contact sitesEndocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceTargeted therapy for advanced gastric cancer: A review of current status and future prospectsNeuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid raftsALG-2 interacting protein-X (Alix) is essential for clathrin-independent endocytosis and signalingThe Road not Taken: Less Traveled Roads from the TGN to the Plasma MembraneEpidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancerYAP and TAZ: a nexus for Hippo signaling and beyondImage-based compound profiling reveals a dual inhibitor of tyrosine kinase and microtubule polymerizationA SPOPL/Cullin-3 ubiquitin ligase complex regulates endocytic trafficking by targeting EPS15 at endosomesAmorphous Silica Particles Relevant in Food Industry Influence Cellular Growth and Associated Signaling Pathways in Human Gastric Carcinoma CellsPTEN modulates EGFR late endocytic trafficking and degradation by dephosphorylating Rab7.Protein redox chemistry: post-translational cysteine modifications that regulate signal transduction and drug pharmacologyNeuropilin-2 Regulates Endosome Maturation and EGFR Trafficking to Support Cancer Cell Pathobiology.Intracellular signaling prevents effective blockade of oncogenic gp130 mutants by neutralizing antibodies.Epidermal Growth Factor Receptor Cell Proliferation Signaling PathwaysNegative regulation of EGFR signalling by the human folliculin tumour suppressor proteinHydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathwaysSynthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells.The Arf6 GTPase-activating proteins ARAP2 and ACAP1 define distinct endosomal compartments that regulate integrin α5β1 traffic.Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model.Squamosamide derivative FLZ protects retinal pigment epithelium cells from oxidative stress through activation of epidermal growth factor receptor (EGFR)-AKT signaling.Pathways driving the endocytosis of mutant and wild-type EGFR in cancer.FBXL20-mediated Vps34 ubiquitination as a p53 controlled checkpoint in regulating autophagy and receptor degradation.Serum and glucocorticoid-inducible kinase1 increases plasma membrane wt-CFTR in human airway epithelial cells by inhibiting its endocytic retrieval.Identification of anti-ErbB2 dual variable domain immunoglobulin (DVD-Ig™) proteins with unique activities.Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9 signaling pathway.The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.Maintenance of glia in the optic lamina is mediated by EGFR signaling by photoreceptors in adult Drosophila.Characterization of differentially expressed genes involved in pathways associated with gastric cancer.Enhancement of NK Cell Cytotoxicity Induced by Long-Term Living in Negatively Charged-Particle Dominant Indoor Air-Conditions.Comprehensive Assessment of Host Responses to 5-Fluorouracil-Induced Oral Mucositis through Transcriptomic AnalysisModification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferonStructural Study of the HD-PTP Bro1 Domain in a Complex with the Core Region of STAM2, a Subunit of ESCRT-0.Opposing Regulation of the EGF Receptor: A Molecular Switch Controlling Cytomegalovirus Latency and Replication.IGFBP2 potentiates nuclear EGFR-STAT3 signaling.Integrin α5 Suppresses the Phosphorylation of Epidermal Growth Factor Receptor and Its Cellular Signaling of Cell Proliferation via N-GlycosylationCarcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR.Stress-induced endocytosis and degradation of epidermal growth factor receptor are two independent processes.MicroRNA-27a functions as a tumor suppressor in renal cell carcinoma by targeting epidermal growth factor receptor.
P2860
Q26700114-5A76593C-24D3-4281-8055-4B06A99B33D0Q26739831-135D33DC-F9C7-42B2-A0B1-1F78B9E22005Q26774138-49119C9D-02FD-47F4-A975-D0B0C3780A1CQ27319837-DFC312DE-A1FF-4B25-B066-ED4E5C1B8759Q27348726-2CE6A5F3-1FE7-457C-878E-B73696B1090EQ28082121-9BA482B1-F94E-421A-8545-6F49E27EF3CAQ28084216-8EB08C82-8B9F-4B76-A8C0-9CFA24BE5502Q28085636-D5D0DEA9-CC55-4D73-9353-9569393B1F40Q28834113-C211FDDA-A5DA-4A5C-92DA-652EB957C66EQ28834146-2640AEEE-E354-4F35-9FFD-A5D4F91AE9F7Q29249068-7F131FF9-2077-4143-99DA-BD4F557883CEQ30360337-2562F593-BB76-4753-877C-A370E502C666Q30368044-346870DF-C3E2-4F40-B543-C39ECDD86C3FQ30699331-DC9131D4-9121-47EA-94C2-5E1ACDF2DFB1Q33557104-C79EDFF4-8F17-4E98-838D-1DCEDAED4A7EQ33737298-C68B3DF4-FAD5-4B18-90DA-041E1B544E84Q33861388-3533883D-B01E-4084-ACB3-E81BA47003AEQ33895006-C3C7E367-F16D-4A28-B264-AA878A2F3BE1Q33898658-D6B77E51-E2DD-42F1-88C7-FAC53C026212Q34430873-B1BF0B2F-E08A-4179-8E6C-B70E7A9ADD76Q34483608-8C6525D3-09EC-4A11-ACD9-87DA679B6FF3Q34486928-35BDF691-8300-46F6-B925-DAAD0CF59759Q34781357-111FA748-685F-42D5-9967-06CA384D2D89Q34981648-C41FBB42-887A-4802-A48A-D90B4341EAE6Q35107706-625EBB53-173E-49FE-ACAC-01E8084EC6D0Q35168105-05C09434-1CE4-482A-A052-14A03F491F07Q35209068-A3F0ED7D-C387-434D-B9ED-99EA5FD2D763Q35228445-AD36AC72-640A-4EB8-ADA3-231D35585B96Q35536431-8D7C867B-D974-4F42-939C-97FF484F0B89Q35557670-C43FE802-D8B7-420D-8544-2858A7CE57E0Q35691005-6A4E262D-DCEA-4F78-AFB4-B7E6CA3D7D64Q35743724-D59206E3-1C2E-47A6-80FF-8F5B1E726FEBQ35852773-8807D90C-7A89-4057-8552-C80271A723F4Q35920656-C9708E5A-CF17-4184-B7BA-894CAD79F3A3Q36027770-7AA4C540-EAC3-40DC-A2C8-D8B0ED018EBCQ36189855-2CB0ABEC-9BFD-4C6A-A464-088D42F481D6Q36444060-20667547-079B-4306-A51F-951111D63B79Q36462450-38B5052B-C648-4785-8AED-232D1138F48EQ36748735-6D070285-8546-4F8C-8D97-CA27EF0D6D69Q36954217-61F4FE90-BDB9-42DD-BEF5-86A0E3F78C32
P2860
EGF receptor trafficking: consequences for signaling and cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
EGF receptor trafficking: consequences for signaling and cancer
@ast
EGF receptor trafficking: consequences for signaling and cancer
@en
EGF receptor trafficking: consequences for signaling and cancer
@nl
type
label
EGF receptor trafficking: consequences for signaling and cancer
@ast
EGF receptor trafficking: consequences for signaling and cancer
@en
EGF receptor trafficking: consequences for signaling and cancer
@nl
prefLabel
EGF receptor trafficking: consequences for signaling and cancer
@ast
EGF receptor trafficking: consequences for signaling and cancer
@en
EGF receptor trafficking: consequences for signaling and cancer
@nl
P2860
P50
P921
P3181
P1476
EGF receptor trafficking: consequences for signaling and cancer
@en
P2093
Clare E. Futter
Emily R. Eden
P2860
P3181
P356
10.1016/J.TCB.2013.11.002
P407
P577
2013-11-29T00:00:00Z